These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy. Ito T; Butler JR; Noguchi D; Ha M; Aziz A; Agopian VG; DiNorcia J; Yersiz H; Farmer DG; Busuttil RW; Hong JC; Kaldas FM Liver Transpl; 2022 Mar; 28(3):386-396. PubMed ID: 34482610 [TBL] [Abstract][Full Text] [Related]
4. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis. Kamarajah SK; Bednar F; Cho CS; Nathan H Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344 [TBL] [Abstract][Full Text] [Related]
5. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection. Hassan H; Chakrabarti S; Zemla T; Yin J; Wookey V; Prasai K; Abdellatief A; Katta R; Tran N; Jin Z; Cleary S; Roberts L; Mahipal A Eur J Surg Oncol; 2023 Nov; 49(11):106994. PubMed ID: 37524649 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis. Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290 [TBL] [Abstract][Full Text] [Related]
7. Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification. Tawarungruang C; Khuntikeo N; Chamadol N; Laopaiboon V; Thuanman J; Thinkhamrop K; Kelly M; Thinkhamrop B BMC Cancer; 2021 May; 21(1):497. PubMed ID: 33941120 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection. Li XH; Zhao CY; Zhou EL; Lin XJ BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up-front resection for resectable intrahepatic cholangiocarcinoma: A propensity-matched analysis. Wehrle CJ; Chang J; Woo K; Gross A; Naples R; Dahdaleh F; Stackhouse K; Kim J; Augustin T; Simon R; Joyce D; Kwon DCH; Miller C; Walsh RM; Aucejo F; Naffouje S J Surg Oncol; 2024 Sep; 130(3):453-461. PubMed ID: 39082443 [TBL] [Abstract][Full Text] [Related]
10. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477 [TBL] [Abstract][Full Text] [Related]
11. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. Sutton TL; Billingsley KG; Walker BS; Enestvedt CK; Dewey EN; Orloff SL; Mayo SC Am J Surg; 2021 Jun; 221(6):1182-1187. PubMed ID: 33707077 [TBL] [Abstract][Full Text] [Related]
13. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma. Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208 [TBL] [Abstract][Full Text] [Related]
14. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332 [TBL] [Abstract][Full Text] [Related]